Morgan Stanley Mannkind Corp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Mannkind Corp stock. As of the latest transaction made, Morgan Stanley holds 2,298,955 shares of MNKD stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,298,955

Previous 1,916,235 19.97%

Holding current value

$14 Million

Previous $10 Million 44.34%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $1.92 Million - $2.56 Million	382,720 Added 19.97%	2,298,955 $14.4 Million
Q2 2024 Oct 17, 2024	SELL	$4.05 - $5.43 $1.77 Million - $2.37 Million	-436,644 Reduced 18.56%	1,916,235 $10 Million
Q2 2024 Aug 14, 2024	SELL	$4.05 - $5.43 $1.77 Million - $2.37 Million	-436,644 Reduced 18.56%	1,916,235 $10 Million
Q1 2024 Oct 17, 2024	BUY	$3.25 - $5.27 $1.42 Million - $2.3 Million	436,644 Added 22.79%	2,352,879 $10.7 Million
Q1 2024 Aug 16, 2024	BUY	$3.25 - $5.27 $3.95 Million - $6.41 Million	1,216,079 Added 106.97%	2,352,879 $10.7 Million
Q1 2024 May 15, 2024	BUY	$3.25 - $5.27 $3.95 Million - $6.41 Million	1,216,079 Added 106.97%	2,352,879 $10.7 Million
Q4 2023 Aug 16, 2024	SELL	$3.34 - $4.29 $2.6 Million - $3.34 Million	-779,435 Reduced 40.68%	1,136,800 $4.14 Million
Q4 2023 Feb 13, 2024	BUY	$3.34 - $4.29 $911,820 - $1.17 Million	273,000 Added 31.6%	1,136,800 $4.14 Million
Q3 2023 Nov 15, 2023	SELL	$3.91 - $5.45 $681,904 - $950,480	-174,400 Reduced 16.8%	863,800 $3.57 Million
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $1 Million - $1.29 Million	-269,120 Reduced 20.59%	1,038,200 $4.23 Million
Q1 2023 May 15, 2023	SELL	$3.95 - $5.63 $959,107 - $1.37 Million	-242,812 Reduced 15.66%	1,307,320 $5.36 Million
Q4 2022 Feb 14, 2023	SELL	$3.02 - $5.37 $2 Million - $3.56 Million	-662,256 Reduced 29.93%	1,550,132 $8.17 Million
Q3 2022 Nov 14, 2022	SELL	$2.99 - $4.35 $2.25 Million - $3.27 Million	-751,761 Reduced 25.36%	2,212,388 $6.84 Million
Q2 2022 Oct 27, 2022	BUY	$2.67 - $4.77 $4.68 Million - $8.37 Million	1,754,108 Added 144.96%	2,964,149 $11.3 Million
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $4.68 Million - $8.37 Million	1,754,108 Added 144.96%	2,964,149 $11.3 Million
Q1 2022 Oct 27, 2022	SELL	$2.62 - $4.45 $4.6 Million - $7.81 Million	-1,754,108 Reduced 59.18%	1,210,041 $4.45 Million
Q1 2022 May 13, 2022	BUY	$2.62 - $4.45 $141,773 - $240,798	54,112 Added 4.68%	1,210,041 $4.45 Million
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $641,791 - $850,967	-158,467 Reduced 12.06%	1,155,929 $5.05 Million
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $5.11 Million - $7.2 Million	1,314,396 New	1,314,396 $5.72 Million

Others Institutions Holding MNKD

# of Institutions

244

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account